Sort   by:  
 Page size 
UnknownComparative risk evaluation for cardiovascular events associated with dapagliflozin vs. empagliflozin in real-world type 2 diabetes patients: a multi-institutional cohort study.
Not available
S-EPMC6760106 | biostudies-literature
UnknownAhR-ROR-γt complex is a therapeutic target for MAP4K3/GLKhighIL-17Ahigh subpopulation of systemic lupus erythematosus.
Not available
S-EPMC6766655 | biostudies-literature
UnknownComprehensive functional genomic analyses link APC somatic mutation and mRNA-miRNA networks to the clinical outcome of stage-III colorectal cancer patients.
Not available
S-EPMC9250073 | biostudies-literature
UnknownEffect of Trehalose Supplementation on Autophagy and Cystogenesis in a Mouse Model of Polycystic Kidney Disease.
Not available
S-EPMC6356442 | biostudies-literature
UnknownImplication of the IL-10-Expression Signature in the Pathogenicity of Leptospira-Infected Macrophages.
Not available
S-EPMC9241676 | biostudies-literature
UnknownDecreased Expression of Estrogen Receptors Is Associated with Tumorigenesis in Papillary Thyroid Carcinoma.
Not available
S-EPMC8835567 | biostudies-literature
UnknownImmune checkpoint inhibitor-induced severe epidermal necrolysis mediated by macrophage-derived CXCL10 and abated by TNF blockade.
Not available
S-EPMC11685864 | biostudies-literature
UnknownPTPRT and PTPRD Deleterious Mutations and Deletion Predict Bevacizumab Resistance in Metastatic Colorectal Cancer Patients.
Not available
S-EPMC6162606 | biostudies-literature
UnknownUncovering latent infections in kidneys: A novel molecular approach for differential Leptospira detection.
Not available
S-EPMC11650133 | biostudies-literature
UnknownTP53 DNA Binding Domain Mutations Predict Progression-Free Survival of Bevacizumab Therapy in Metastatic Colorectal Cancer.
Not available
S-EPMC6721375 | biostudies-literature
Sort   by:  
 Page size